Sign in
A randomized, double-blind, placebo-controlled trial of coenzyme Q10 in Huntington disease
Journal article   Open access  Peer reviewed

A randomized, double-blind, placebo-controlled trial of coenzyme Q10 in Huntington disease

Andrew McGarry, Michael McDermott, Karl Kieburtz, Elisabeth A de Blieck, Flint Beal, Karen Marder, Christopher Ross, Ira Shoulson, Peter Gilbert, William M Mallonee, …
Neurology, Vol.88(2), pp.152-159
2017-01-10
PMCID: PMC5224719
PMID: 27913695

Abstract

Double-Blind Method United States Humans Middle Aged Ubiquinone - analogs & derivatives Proportional Hazards Models Male Treatment Outcome International Cooperation Vitamins - therapeutic use Canada Ubiquinone - therapeutic use Adult Female Retrospective Studies Australia Huntington Disease - drug therapy
url
https://doi.org/10.1212/WNL.0000000000003478View
Published (Version of record) Open

InCites Highlights

These are selected metrics from InCites Benchmarking & Analytics tool, related to this output

Collaboration types
Domestic collaboration
International collaboration
Citation topics
1 Clinical & Life Sciences
1.52 Neurodegenerative Diseases
1.52.951 Huntington's Disease
Web Of Science research areas
Clinical Neurology
ESI research areas
Neuroscience & Behavior

UN Sustainable Development Goals (SDGs)

This output has contributed to the advancement of the following goals:

#3 Good Health and Well-Being

Source: InCites

Details